Abstract
Fractures of the tibia are frequently treated with an intra-medullary nail. This can be inserted through either a supra-patella or infra-patella surgical incision. Concerns over potential damage to the cartilage of the knee with supra-patella insertion has impacted upon its adoption despite benefits in terms of easier nail placement and potentially reduced blood loss and pain.
This randomised pilot study will use patient reported outcome measures (PROMS) and novel MRI sequences designed to assess damage to the structure of cartilage to compare these two methods of tibial intra-medullary nailing.
Twenty individuals with tibial shaft fractures will be randomised to either method of nail insertion (ten individuals in each arm). MRI scans and PROMS will be used to assess cartilage damage and general function up to 6 months post operatively.
The results of the study will be used to inform a potential multi-centre study.
Competing Interest Statement
All authors declare funding from Addenbrooke's Charitable Trust to support this project. The Department of Trauma and Orthopaedics at Addenbrooke's Hospital receives funding from Depuy Synthes to support a Trauma Fellow post. BMD reports funding from an NIHR Clinical Lectureship, not directly related to this study. EA has nothing else to declare. DC has nothing else to declare. PH has nothing else to declare. JW has nothing else to declare. JMcK reports grants and/or consultancy payments from GlaxoSmithKline, Moximed, GE Healthcare, and employment by AstraZeneca, none directly related to this study. AMcC reports work for Taylor and Francis (publishers), membership of an advisory board for Arthritis Research UK, and a patent for cartilage repair unrelated to this study. AC reports grants and/or consultancy payments from NIHR, Stryker, Matortho, Zimmer Biomet, as well as income from expert testimony, none directly related to this study.
Clinical Trial
NCT04831671
Funding Statement
This study was funded by Addenbrooke's Charitable Trust.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
East of England Cambridge South Research Ethics Committee (reference 21/EE/0178) of the NHS gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declarations of Interest
All authors declare funding from Addenbrooke’s Charitable Trust to support this project.
The Department of Trauma and Orthopaedics at Addenbrooke’s Hospital receives funding from Depuy Synthes to support a Trauma Fellow post.
BMD reports funding from an NIHR Clinical Lectureship, not directly related to this study.
EA has nothing else to declare.
DC has nothing else to declare.
PH has nothing else to declare.
JW has nothing else to declare.
JMcK reports grants and/or consultancy payments from GlaxoSmithKline, Moximed, GE Healthcare, and employment by AstraZeneca, none directly related to this study.
AMcC reports work for Taylor and Francis (publishers), membership of an advisory board for Arthritis Research UK, and a patent for cartilage repair unrelated to this study.
AC reports grants and/or consultancy payments from NIHR, Stryker, Matortho, Zimmer Biomet, as well as income from expert testimony, none directly related to this study.
Data Availability
No data is available as this is only the study protocol.